Fidelity Investments’s BioVie BIVI Stock Holding History

Fidelity Investments’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2	Buy	+1	New	+$2	﹤0.01%	5551
2026 Q1	–	Sell	-16,294	Closed	-$20.9K	–	5436
2025 Q4	$18.9K	Buy	+16,294	New	+$26.2K	﹤0.01%	4482
2024 Q3	–	Sell	-29	Closed	-$1.18K	–	5504
2024 Q2	$1.18K	Sell	29 -33	-53%	-$1.58K	﹤0.01%	4785
2024 Q1	$3.27K	Buy	62 +60	+3,000%	+$6.15K	﹤0.01%	4607
2023 Q4	$218	Sell	2 -2	-50%	-$601	﹤0.01%	4878
2023 Q3	$1.27K	Buy	4 +3	+300%	+$1.17K	﹤0.01%	4616
2023 Q2	$340	Buy	+1	New	+$674	﹤0.01%	4856

Other funds holding BIVI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PTC

Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

Fidelity Investments's BIVI Position: Q2 2026 in Review

Fidelity Investments opened a new position in BioVie (BIVI) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #5551 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in BIVI as recently as Q4 2025.

Fidelity Investments first reported a position in BIVI in Q2 2023 and has held it in 7 quarters since. The position peaked at $18.9K in Q4 2025. 36 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

Fidelity Investments held 1 share of BioVie worth $2 as of Q2 2026.
BioVie was a new Fidelity Investments position in Q2 2026.
BioVie made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5551 holding.
Fidelity Investments first reported a position in BioVie in Q2 2023 and has held it in 7 quarters since.
Fidelity Investments's BioVie position peaked at $18.9K in Q4 2025.
36 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.